RELATED CONTENT
December 28, 2015 — IBA (Ion Beam Applications SA) has signed a contract with TMS (Tomorrow Medical Systems Co. Ltd.) ...
December 28, 2015 
IBA (Ion Beam Applications S.A.) announced that the newly opened Texas Center for Proton Therapy is now treating cancer patients, using image-guided Pencil Beam Scanning (PBS).
November 23, 2015 
IBA announced that longtime customer and research partner Penn Medicine has upgraded the equipment of its Roberts Proton Therapy Center with the latest innovations in proton therapy treatment. This upgrade to the newest technologies will allow Penn Medicine’s staff to continue to offer top-level proton radiation therapy services to an increasing number of patients and to further advance the clinical application of proton therapy.
October 27, 2015 
IBA announced that a breast cancer patient at Willis-Knighton Cancer Center has received the first U.S. Food and Drug Administration (FDA)-approved compact proton therapy treatment with cone beam computed tomography (CBCT). The treatment was completed using IBA’s Proteus One system.
October 23, 2015 
IBA announced that Korea’s National Cancer Center (NCC) has recently installed and deployed its pencil beam scanning (PBS) delivery modality. On Sept. 22, PBS treatment was initiated for the first cancer patient to benefit from the superior precision of this delivery technique in Korea.
October 20, 2015 
IBA (Ion Beam Applications S.A.) announced the successful response of over 120 attendees for the live webinar “Electronic Recordkeeping in Radiation Therapy” delivered Sept. 23, 2015. The webinar was hosted by Medical Physics Web with funding provided by an IBA educational grant and was presented by James Nunn, MS, CHP, DABR, senior medical physicist at LewisGale Regional Hospital in Virginia.
October 16, 2015 
IBA (Ion Beam Applications S.A.) announced the second release of its myQA global quality assurance platform.
October 02, 2015 IBA (Ion Beam Applications SA) announced that it has signed a contract with the company INVAP for the installation of a proton therapy center at the Instituto de Oncologia Angel Roffo hospital in Buenos Aires, Argentina.
September 21, 2015 
Zevacor Molecular (Zevacor), manufacturer and distributor of positron emission tomography (PET) and single photon emission computed tomography (SPECT) radiopharmaceuticals, announced the arrival of a 70 MeV Cyclotron at its new production facility in Noblesville, Indiana.
September 11, 2015 The current state of proton therapy can be assessed fairly quickly by looking at a map: At the end of 2014, there were ...
September 09, 2015